Renal autotransplantation with ex vivo bench surgery preserves kidney in hilar pheochromocytomaNew kidney preservation method shows promise for a rare tumor

This publication is a case report accompanied by a literature review, focused on a 37-year-old man with a left adrenal pheochromocytoma. The intervention described is renal autotransplantation combined with ex vivo bench surgery, a kidney-preserving approach intended to allow tumor resection while maintaining renal function.

The report states that at 2 years of follow-up, blood pressure remained normal, renal function remained normal, and there was no evidence of recurrence. No effect sizes, absolute numbers, or statistical comparisons were reported. Safety outcomes, including adverse events and tolerability, were not reported.

The authors acknowledge that the evidence is limited to a single case report. No comparator group was described, and the setting, funding, and conflicts of interest were not reported. These factors limit any inference about efficacy or comparative benefit.

The authors suggest that renal autotransplantation with ex vivo bench surgery is a feasible kidney-preserving strategy for pheochromocytomas involving the renal hilar vessels. However, given the anecdotal nature of the evidence, this should be interpreted as hypothesis-generating rather than practice-changing. Clinicians should recognize the potential role of this approach in selected cases but await broader experience before adopting it routinely.